New YorkLondonTokyoSydneyToronto
BIOPHARMA HEADLINES
Biotech

Oncolytics Reports HPV-Specific Immune Responses in Pelareorep Anal Cancer Study

Oncolytics reports HPV-specific immune responses in small anal cancer study subsets, adding biological support for further development of its investigational pelareorep combination.

NASDAQ:ONCYNYSE:NVONASDAQ:MRNA

THE NEWS DESK

Latest headlines.